| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K24HL127301 | Mentoring in Translational Research in Interstitial Lung Diseases | 000 | 12 | NIH | 10/8/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $202,086,501 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NR021880 | The Worksite Heart Health Improvement Project + Function Focused Care (WHHIP+FFC) intervention to increase physical activity and wellbeing among staff and residents in assisted living facilities | 000 | 1 | NIH | 7/21/2026 | $744,172 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM158124 | The Effects of Anesthetic and Sedative Exposure on Brain Development | 001 | 2 | NIH | 9/9/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DA041117 | 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | 000 | 12 | NIH | 4/2/2026 | $1,863,099 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08NS140393 | The Role of STRADA in Inhibitory Neuron Migration and Corticogenesis | 000 | 2 | NIH | 8/7/2026 | $228,555 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS117102 | Stem Cell Surface Modification to Promote Nerve Regeneration | 001 | 5 | NIH | 3/5/2026 | $42,994 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL167012 | A mechanistic understanding of treatment-related outcomes of sleep disordered breathing using functional near infrared spectroscopy | 000 | 4 | NIH | 5/27/2026 | $582,192 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS117102 | Stem Cell Surface Modification to Promote Nerve Regeneration | 000 | 5 | NIH | 12/18/2025 | $386,953 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | The development a new Multidimensional and Multilevel Measure of Institutional and Economic Barriers for English and Spanish speaking populations | 001 | 4 | NIH | 4/24/2026 | $3,078 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | The development a new Multidimensional and Multilevel Measure of Institutional and Economic Barriers for English and Spanish speaking populations | 000 | 4 | NIH | 4/14/2026 | $620,272 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 001 | 3 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 000 | 3 | NIH | 3/25/2026 | $36,902 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM160046 | Regulation of canonical and non-canonical substrates of histone lysine methyltransferases | 000 | 2 | NIH | 9/17/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI187023 | Epitope-Paratope Characteristics and IgG1 Allostery in Fc-mediated Effector Function | 000 | 2 | NIH | 7/21/2026 | $664,389 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA063051 | Behavioral and neurobiological mechanisms of reciprocal social interactions in Substance Use Disorders | 000 | 2 | NIH | 3/19/2026 | $641,450 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 000 | 5 | NIH | 4/6/2026 | $613,747 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA039062 | Endocannabinoids regulate microglia in developing brain | 000 | 10 | NIH | 2/27/2026 | $469,533 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI134696 | Tick Saliva and Pathogen Transmission | 000 | 8 | NIH | 6/15/2026 | $753,855 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR071614 | Osteocyte CaMKII as a Critical Regulator of Bone Physiology and Anabolism | 000 | 7 | NIH | 5/11/2026 | $543,211 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW013007 | Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program | 001 | 2 | NIH | 8/5/2026 | $87,588 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL098032 | Omics, mice and men: Development of precision transfusion medicine | 000 | 17 | NIH | 7/30/2026 | $749,374 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW013007 | Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program | 000 | 2 | NIH | 7/24/2026 | $160,738 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW012997 | Establishing a Sustainable Master's Degree Program in Research Ethics and Integrity in Morocco | 000 | 2 | NIH | 7/1/2026 | $248,399 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01ES033301 | Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney | 000 | 5 | NIH | 4/1/2026 | $363,710 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL139613 | Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension | 000 | 8 | NIH | 6/11/2026 | $560,096 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032225 | The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | 000 | 4 | NIH | 8/10/2026 | $255,985 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032225 | The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | 000 | 4 | NIH | 8/10/2026 | $215,441 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA061796 | Mechanistic Evaluation of Gabapentin and Opioid Polypharmacy | 001 | 1 | NIH | 6/3/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA061796 | Mechanistic Evaluation of Gabapentin and Opioid Polypharmacy | 000 | 1 | NIH | 5/28/2026 | $659,796 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NR021713 | Empowering Baltimore youth through applied research experiences to improve diet quality in older adults living in healthy food priority areas | 000 | 1 | NIH | 5/21/2026 | $2,160,854 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03HL188068 | Comparative Cardiovascular Effects of Combustible and Electronic Cigarettes in Older Adults with Hypertension | 000 | 1 | NIH | 8/14/2026 | $116,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI189709 | Dynamic metabolic rewiring determines immune outcomes of chronic cardiac transplant outcomes | 000 | 1 | NIH | 8/3/2026 | $770,199 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI198875 | Host-pathogen-microbiome interactions in Mycoplasma genitalium pathology and treatment: experiments in a 3D organotypic cervical epithelium model to strengthen clinical guidelines | 000 | 1 | NIH | 6/10/2026 | $194,375 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01AI189332 | Molecular determinants of vaccine-induced antibody durability | 001 | 2 | NIH | 8/18/2026 | $792,878 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 000 | 1 | NIH | 2/6/2026 | $48,290 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR086894 | Defining the role of SLC9A1 in fibroblast pathobiology during Systemic Sclerosis and Systemic Sclerosis-associated Interstitial Lung Disease | 000 | 1 | NIH | 8/26/2026 | $608,966 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 002 | 1 | NIH | 3/25/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 001 | 1 | NIH | 2/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R56CA308267 | Algorithms for HLA-E based cancer immunotherapy | 000 | 1 | NIH | 8/26/2026 | $75,000 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08NS148716 | Role of the Choroid Plexus in Neutrophil Recruitment After Traumatic Brain Injury | 000 | 1 | NIH | 8/14/2026 | $229,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AG098680 | Novel Approaches to Remove Systematic Prediction Bias in Machine-Learning Regression for Biological Age | 000 | 1 | NIH | 8/14/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21HD122069 | Targeting post-stroke upper extremity paresis through a synergy between ischemic and mechanical stress | 000 | 1 | NIH | 8/26/2026 | $433,595 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01LM015041 | Incorporating the Missing Time Dimension into Identity-by-Descent-based Malaria Genomic Surveillance | 000 | 1 | NIH | 9/1/2026 | $1,399,500 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS124687 | Bidirectional Brain-Gut interactions, chronic neuroinflammation and neurodegeneration after traumatic brain injury | 000 | 5 | NIH | 8/11/2026 | $510,554 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R56AI201418 | Optimization of Immunomodulation Strategies to Overcome Cardiac Xenograft Rejection | 000 | 1 | NIH | 8/26/2026 | $777,421 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS124687 | Bidirectional Brain-Gut interactions, chronic neuroinflammation and neurodegeneration after traumatic brain injury | 000 | 5 | NIH | 8/11/2026 | $108,300 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31AA032965 | Disynaptic circuit control of inflexible alcohol behaviors | 001 | 1 | NIH | 7/22/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31AA032965 | Disynaptic circuit control of inflexible alcohol behaviors | 000 | 1 | NIH | 7/22/2026 | $40,624 |
|
